Inmolecule Nanotech (XPAR:MLINA) Other Stockholders Equity: €-0.80 Mil (As of Dec. 2024)


XPAR:MLINA Inmolecule Nanotech SA XPAR:MLINA
6 GF Score
Price €4.08
! 2 Warning Signs
View Full Analysis

What is Inmolecule Nanotech Other Stockholders Equity?

Inmolecule Nanotech XPAR:MLINA 6 Other Stockholders Equity is €-0.80 Mil as of Dec. 2024. GuruFocus rates XPAR:MLINA with a GF Score™ of 6/100. The stock has 2 warning signs investors should review.

Inmolecule Nanotech's Other Stockholders Equity for the quarter that ended in Dec. 2024 was €-0.80 Mil.

Inmolecule Nanotech's quarterly Other Stockholders Equity increased from . 20 (€0.00 Mil) to Dec. 2023 (€0.12 Mil) but then declined from Dec. 2023 (€0.12 Mil) to Dec. 2024 (€-0.80 Mil).

Inmolecule Nanotech's annual Other Stockholders Equity increased from . 20 (€0.00 Mil) to Dec. 2023 (€0.12 Mil) but then declined from Dec. 2023 (€0.12 Mil) to Dec. 2024 (€-0.80 Mil).

Inmolecule Nanotech Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Inmolecule Nanotech's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Inmolecule Nanotech Other Stockholders Equity Chart

Inmolecule Nanotech Annual Data
Trend Dec23 Dec24
Other Stockholders Equity
0.12 -0.80

Inmolecule Nanotech Semi-Annual Data
Dec23 Dec24
Other Stockholders Equity 0.12 -0.80
XPAR:MLINA
6GF Score
Inmolecule Nanotech SA XPAR:MLINA
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Inmolecule Nanotech Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of €-0.80 Mil mean?
Inmolecule Nanotech (XPAR:MLINA) has a Other Stockholders Equity of €-0.80 Mil as of Dec. 2024. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Inmolecule Nanotech and its competitors.
Is Inmolecule Nanotech's Other Stockholders Equity too high?
Inmolecule Nanotech's current Other Stockholders Equity is €-0.80 Mil. Overall, Inmolecule Nanotech has a GF Score™ of 6/100, reflecting its overall financial health beyond just this single metric.
How does Inmolecule Nanotech's Other Stockholders Equity compare to VRTX and REGN?
Inmolecule Nanotech's Other Stockholders Equity of €-0.80 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Biotechnology company?
A good Other Stockholders Equity depends on the Biotechnology industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Inmolecule Nanotech and its competitors. Inmolecule Nanotech's current Other Stockholders Equity is €-0.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Inmolecule Nanotech stock overvalued right now?
Inmolecule Nanotech (XPAR:MLINA) has a current Other Stockholders Equity of €-0.80 Mil. The current Other Stockholders Equity is €-0.80 Mil. Inmolecule Nanotech's overall GF Score™ is 6/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Inmolecule Nanotech (XPAR:MLINA), the current Other Stockholders Equity is €-0.80 Mil as of Dec. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Inmolecule Nanotech Business Description

Address Paseo de la Castellana 91, 4th Floor, Madrid, ESP, 28046
Inmolecule Nanotech SA is a research and development company. The company provides health care, home care and personal care products.
6GF Score

Get the complete analysis for XPAR:MLINA

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€4.08
Price